吉格列汀(rINN)以前被鉴定为LC15-0444,是新型二肽基肽酶-4(DPP-4)抑制剂类药物的口服抗高血糖剂(抗糖尿病药物)。众所周知,DPP-4抑制剂的降糖作用主要由GLP-1和胃抑制多肽(GIP)内分泌激素介导,而胃抑制多肽(GIP)内分泌激素被DPP-4失活。

清空选项
1676-90-0

BD187921676-90-097%

¥102.005g常备现货

98977-36-7

BD030898977-36-798%

¥34.001g常备现货

647863-25-0

BD241608647863-25-095+%

¥4788.001g

911634-75-8

BD564396911634-75-897%

¥1326.00250mg

911636-87-8

BD316092911636-87-895+%

¥暂无

153287-86-6

BD118220153287-86-695%

¥575.00250mg

911636-86-7

BD316091911636-86-795+%

¥暂无

1